Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference23 articles.
1. Concept, Strategies, and Feasibility of Noninvasive Insulin Delivery
2. Clinical Pharmacokinetics and Pharmacodynamics of Inhaled Insulin
3. 3 American Conference of Governmental Industrial Hygienists. 1993-94 Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. OH, Cincinnati, 1993, 29 .
4. Inhaled insulin1Abbreviations: DM, diabetes mellitus; AIDs, acquired immune deficiency syndrome; SC, subcutaneous; DCCT, Diabetes Control and Complications Trial; IDDM, insulin-dependent diabetes mellitus; NIDDM, non-insulin-dependent diabetes mellitus; i.v., intravenous; DDPC, di-decanoyl-alpha-phosphatidylcholine; AUC, area under the curve; INH, inhaled; Cmax, maximum serum concentration; Cmin, minimum serum concentration; Tmax, time of maximum serum concentration; NS, not significant; HbA1c, hemoglobin A1c; OA, oral agent; SD, standard deviation; MDI, metered dose inhaler; DPI, dry powder inhaler; MMAD, mass median aerodynamic diameter; CMC, critical micelle concentration; SR, sustained release; PLGA, poly lactic acid-co-glycolic acid; GI, gastrointestinal, GSD, geometric standard deviation; TLC, total lung capacity; VC, vital capacity; SMK, smokers; MW, molecular weight; MP, melting point.1
5. 5 SJ Smith, JA. Bernstein, and AJ Hickey ed. Inhalation Aerosols: Physical and Biological Basis for Therapy . New York, NY: Marcel Dekker, 1996, 233 -269 .
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献